Download - Contrast Media and Adverse Effects
-
8/6/2019 Contrast Media and Adverse Effects
1/42
CONTRAST MEDIA AND ADVERSECONTRAST MEDIA AND ADVERSE
EFFECTSEFFECTS
Moderator :Moderator : Mr. L.K. GuptaMr. L.K. Gupta
Presenter :Presenter : Vijay KumarVijay KumarB.Sc Final Year StudentB.Sc Final Year Student
Department of Radiodiagnosis, PGIMER, ChandigarhDepartment of Radiodiagnosis, PGIMER, Chandigarh
-
8/6/2019 Contrast Media and Adverse Effects
2/42
INTRODUCTIONINTRODUCTION
Contrast media are those substances which areContrast media are those substances which areusedused
to distinguish between organ and tissues, vesselsto distinguish between organ and tissues, vesselsbyby
introducing different methods. Contrast mediaintroducing different methods. Contrast mediadiffers asdiffers as
the attenuation and absorption of radiation. Contrastthe attenuation and absorption of radiation. Contrast
media having high atomic number and attenuationmedia having high atomic number and attenuationandand
absorption is more so it appears white in theabsorption is more so it appears white in the
-
8/6/2019 Contrast Media and Adverse Effects
3/42
HISTORICAL DEVELOPMENTHISTORICAL DEVELOPMENT
InIn 19231923 firstfirst reportreport ofof opacificationopacification ofof thethe urinaryurinary tracttract byby
renalrenal excretionexcretion byby retrograderetrograde introductionintroduction ofof contrastcontrastagentagent
withwith thethe useuse ofof 1010%% sodiumsodium iodideiodide.. ThisThis waswas followedfollowedbyby
iodineiodine derivativesderivatives ofof pyridonepyridone ee..gg.. ofof thethe firstfirst contrastcontrastmediamedia
waswas uroselectianuroselectian andand diodonediodone (diotrast)(diotrast) whichwhich werewereutilizedutilized
inin urographyurography fromfrom thethe 19301930.. InIn 19501950 thatthat thethe modernmodern
waterwater
-
8/6/2019 Contrast Media and Adverse Effects
4/42
In 1955 a much safer derivative was reported Diatrizoate. ThisIn 1955 a much safer derivative was reported Diatrizoate. This
hadhadon acetamido group. Isomerization of diatrizoate andon acetamido group. Isomerization of diatrizoate and
iothalamateiothalamate
molecule in 1962. The majority of the modern conventionalmolecule in 1962. The majority of the modern conventional
waterwatersoluble contrast media was developed. It contains sodium andsoluble contrast media was developed. It contains sodium and
meglumine. These contrast are Hypertonic with osmolalitis.meglumine. These contrast are Hypertonic with osmolalitis.HyperHyper
osmolality is responsible for many of the adverse effect so lowosmolality is responsible for many of the adverse effect so lowosmolar contrast media was developed which reduce the sideosmolar contrast media was developed which reduce the side
effects. Conventional ionic contrast media have a iodine toeffects. Conventional ionic contrast media have a iodine toparticleparticle
ratio was 3:2. In 1972 a new agent was introduced forratio was 3:2. In 1972 a new agent was introduced for
radiculography. It was iothalamate molecules to form aradiculography. It was iothalamate molecules to form a
HISTORICAL DEVELOPMENT ContdHISTORICAL DEVELOPMENT Contd
-
8/6/2019 Contrast Media and Adverse Effects
5/42
Definition C/MDefinition C/M
The contrast media are the salt of organic iodineThe contrast media are the salt of organic iodinecontainingcontaining
molecules. They are introduced into the body for themolecules. They are introduced into the body for thepurposepurpose
of opacifying structure.of opacifying structure.Properties of C/MProperties of C/M
It must be easily availableIt must be easily available
It must be non toxic / non poisonousIt must be non toxic / non poisonous
Viscosity must be adequateViscosity must be adequate
It should not affect locallyIt should not affect locally It must provide adequate contrast for diagnostic purposeIt must provide adequate contrast for diagnostic purpose
It must provide permanent opacification in theIt must provide permanent opacification in the
radiographradiograph
Intrathecal contrast should be missible in CSFIntrathecal contrast should be missible in CSF
-
8/6/2019 Contrast Media and Adverse Effects
6/42
Types of C/M barium CompoundsTypes of C/M barium Compounds
Bariumsuspensionis made up from pure bariumBariumsuspensionis made up from pure bariumsulphatesulphate
It is morphological studies of GI tractIt is morphological studies of GI tract Barium contrast is used in the form of Ba so4Barium contrast is used in the form of Ba so4
BASO 4BASO 4 :: White crystalline powerWhite crystalline power
Molecular weight = 233Molecular weight = 233
Specific gravity = 4.5Specific gravity = 4.5 Atomic number = 56Atomic number = 56
High density barium usually has particle size 5 to 12High density barium usually has particle size 5 to 12micro metermicro meter
Decreasing the particle size increase viscosity.Decreasing the particle size increase viscosity.
TP1
-
8/6/2019 Contrast Media and Adverse Effects
7/42
Slide 6
TP1 The ParadoX, 7/27/2005
-
8/6/2019 Contrast Media and Adverse Effects
8/42
Varieties of Bariumsuppression is usedVarieties of Bariumsuppression is used
ProprietarynameProprietaryname Density W / VDensity W / V
Baritop 100Baritop 100 100%100%
EE--Z HDZ HD 250%250%
Micro opaque DCMicro opaque DC 100%100%
Micro opaque PowderMicro opaque Powder 76%76%
Polibar RapidPolibar Rapid 100%100%
-
8/6/2019 Contrast Media and Adverse Effects
9/42
IndicationsIndications
Suspected perforationSuspected perforation
To distinguish bowel from otherstructures onTo distinguish bowel from otherstructures onCTCT
LOCM is used if aspiration possiblyLOCM is used if aspiration possibly
In the case of GI tract ofneonates and infantsIn the case of GI tract ofneonates and infants When C/M is likely to enter the lungWhen C/M is likely to enter the lung
Possible leakage of contrast media from the GIPossible leakage of contrast media from the GI
tacttact
-
8/6/2019 Contrast Media and Adverse Effects
10/42
AdvantageAdvantage
Rapid absorption of LOCMRapid absorption of LOCM
No damage to bowel mucosaNo damage to bowel mucosa
Veryslow absorption from gutVeryslow absorption from gut
Resulting in good bowel visualizationResulting in good bowel visualization
Stable in bowel secretionStable in bowel secretion No adverse effects on the lungsNo adverse effects on the lungs
-
8/6/2019 Contrast Media and Adverse Effects
11/42
ComplicationsComplications
Pulmonary oedemaPulmonary oedema
Allergic reactionAllergic reaction
May precipitate in hyper chlorohydric gastricMay precipitate in hyper chlorohydric gastric
acidacid
-
8/6/2019 Contrast Media and Adverse Effects
12/42
Iodine containing watersoluble contrast mediaIodine containing watersoluble contrast media
IonicIonic
NonionicNonionicIonic watersaluble c/m (ionic ) (HOCM)Ionic watersaluble c/m (ionic ) (HOCM)
a.a. Urography 60% (TrazografUrography 60% (Trazograf))
79% Na/ diagrizoate79% Na/ diagrizoate
52% meglumine diatrizoate52% meglumine diatrizoate Iodine content 292 mg/ml 5.14gm (In 20ml Solution)Iodine content 292 mg/ml 5.14gm (In 20ml Solution)
B.B. Urografin 76% (Trazograf) 7.4gm (In 20ml Solution)Urografin 76% (Trazograf) 7.4gm (In 20ml Solution)
10% sodium diatrozoate10% sodium diatrozoate
Iodine content 370mg/mlIodine content 370mg/ml
C.C. Trazogastro (Gastrografin ) ORAL contrastTrazogastro (Gastrografin ) ORAL contrast
10% Sodium diatrizoetec10% Sodium diatrizoetec
66% meglime diatrizoate66% meglime diatrizoate
Iodine content 370mg/mlIodine content 370mg/ml
-
8/6/2019 Contrast Media and Adverse Effects
13/42
Table 1Table 1
Type of Contrast AgentsType of Contrast Agents
Table 2Table 2
Conditions associated with adverse reactions to contrastConditions associated with adverse reactions to contrast
MaterialMaterial
Type AgentType Agent
HighHigh
OsmolalityOsmolality
Ionic Diatrizoate sodiumIonic Diatrizoate sodium
(Hypaque)(Hypaque)
LowLow
OsmolalityOsmolalityIonic LoxaglateIonic Loxaglate
megluminemeglumine
(Hexabrix)(Hexabrix)
Nonionic GadodiamideNonionic Gadodiamide
(Omniscan)(Omniscan)GadoteoridolGadoteoridol
(Pro Hance)(Pro Hance)
Iodixanol (Visipaque)Iodixanol (Visipaque)
Iopamidol (Isovue)Iopamidol (Isovue)
Iopromide (Ultravist)Iopromide (Ultravist)Ioversol (Optiary)Ioversol (Optiary)
Preexisting renal insufficiencyPreexisting renal insufficiency
Previous anaphylactoid reaction to contrast materialPrevious anaphylactoid reaction to contrast material
AsthmaAsthma
Food ormedication allergies, or hayfeverFood ormedication allergies, or hayfever
Multiple medical problem or an underlying disease ( e.g. cardiacMultiple medical problem or an underlying disease ( e.g. cardiac
disease, preexisting azotemia)disease, preexisting azotemia)
Treatment with nephrotoxic agents (e.g. aminoglycosides,Treatment with nephrotoxic agents (e.g. aminoglycosides,nonsteroidal antinonsteroidal anti--inflammatory agents)inflammatory agents)
Advanced ageAdvanced age
-
8/6/2019 Contrast Media and Adverse Effects
14/42
-
8/6/2019 Contrast Media and Adverse Effects
15/42
Table 3 Methods ofPreventing ContrastTable 3 Methods ofPreventing Contrast
Material induced renal InsufficiencyMaterial induced renal Insufficiency
General PrincipleGeneral Principle Use the smallest amount of contrast materialUse the smallest amount of contrast materialpossiblepossible
Discontinue othernephrotoxic medications before theDiscontinue othernephrotoxic medications before theprocedureprocedure
Allow two to five days between procedures requiringAllow two to five days between procedures requiring
contrast materialcontrast material
HydrationHydration Oral : 500mL before the procedure and 2,500mL overOral : 500mL before the procedure and 2,500mL overthe 24 hour after the procedurethe 24 hour after the procedure
Intravenous : 0.9% or 0.45% saline 100mL per hourIntravenous : 0.9% or 0.45% saline 100mL per hour
beginning four hours before the procedure andbeginning four hours before the procedure and
continuing for the 24 hourscontinuing for the 24 hours
-
8/6/2019 Contrast Media and Adverse Effects
16/42
-
8/6/2019 Contrast Media and Adverse Effects
17/42
Contrast media MRIContrast media MRI
MR contrast media differentiate tissue structure. EitherMR contrast media differentiate tissue structure. Either
increasing signal intensity on T1 weighted image orincreasing signal intensity on T1 weighted image or
decrease. Signal intensityin T2 weight image to do sodecrease. Signal intensityin T2 weight image to do sodifferent Gadolinium based contrast media are used egdifferent Gadolinium based contrast media are used eg--
diethylene triamine penta acetic acid. 1ml magnavistdiethylene triamine penta acetic acid. 1ml magnavist
containcontain
469mg gadiopentetic acid dimeglumine salt in aquous469mg gadiopentetic acid dimeglumine salt in aquous
solution.solution.
-
8/6/2019 Contrast Media and Adverse Effects
18/42
Indication of MRI ContrastIndication of MRI Contrast
Inter cranial lesion with abnormal VascularityInter cranial lesion with abnormal Vascularity Abnormalityin blood brain barrierAbnormalityin blood brain barrier
Gadopentate enhanced MRI help diagnosis andGadopentate enhanced MRI help diagnosis andcharacterization ofneoplastic diseasecharacterization ofneoplastic disease
Acoustic neuromaAcoustic neuroma Inflammatory diseasesInflammatory diseases
Certain vascular abnormalityCertain vascular abnormality
Demyelating abnormalityDemyelating abnormality
eg multiple sclerosiseg multiple sclerosisWhole Body MRI :Whole Body MRI : Evaluation ofsuspected hepatic lesionEvaluation ofsuspected hepatic lesion
Musculoskeletal lesion. Cardiac MR ImagingMusculoskeletal lesion. Cardiac MR Imaging
-
8/6/2019 Contrast Media and Adverse Effects
19/42
Contra IndicationContra Indication
It should not administer pts having hypersensitivityIt should not administer pts having hypersensitivity
Renal failureRenal failure
Sickle cell anemiaSickle cell anemia
PregnancyPregnancy
-
8/6/2019 Contrast Media and Adverse Effects
20/42
Contrast agentsin ultrasoundContrast agentsin ultrasound
Levovist (Schering)Levovist (Schering)
Widely used inmicrobubbles contrast agentWidely used inmicrobubbles contrast agent
Echovist (Schering) bubblesin a glactose soln butEchovist (Schering) bubblesin a glactose soln butlacking the palmating acid coatinglacking the palmating acid coating
Albunex :Albunex : Airmicro bubble used in echocardiographyAirmicro bubble used in echocardiography
Sonvne :Sonvne : Suspension ofstabilized sulpher hexafluorideSuspension ofstabilized sulpher hexafluoride
microbubblesmicrobubbles
-
8/6/2019 Contrast Media and Adverse Effects
21/42
Uses of C/MUses of C/M
It should be used in various places of diagnosticIt should be used in various places of diagnostic
departmentdepartment
IVUIVU
BariumBarium
MRIMRI
CT AngiographyCT Angiography UltrasoundUltrasound
-
8/6/2019 Contrast Media and Adverse Effects
22/42
Preservation of contrast MediaPreservation of contrast Media
Properstorage dark place 15 degree C to 30degree CProperstorage dark place 15 degree C to 30degree C Observation of expiratory dateObservation of expiratory date It should be form 2It should be form 2--3 to3 to
5 years5 years
Examination of the C/M solution before used check theExamination of the C/M solution before used check the
cleanness ofsolution.cleanness ofsolution. Crystallization found insolution then the contrastCrystallization found insolution then the contrast
media which is at low tamp is heated upto 80 degree Cmedia which is at low tamp is heated upto 80 degree C
C/M solution with high viscosity at 37 degree C heatC/M solution with high viscosity at 37 degree C heatreduces the viscosityreduces the viscosity
Risk ofmicrobial contamination for we should not leaveRisk ofmicrobial contamination for we should not leavethe solution open formore than 4 hoursthe solution open formore than 4 hours
Resterlization of the C/M solutionResterlization of the C/M solution do not resterlizationdo not resterlizationthe open containerthe open container
Transfer to the sterile containerTransfer to the sterile container
-
8/6/2019 Contrast Media and Adverse Effects
23/42
Mechanism of contrast media reactionMechanism of contrast media reaction
OverdoseOverdose :: Some kinds of patientsmay be overdose withSome kinds of patientsmay be overdose withC/MC/M
small infants having multiple injection during angio cardiosmall infants having multiple injection during angio cardiographygraphy
and adults with cardiac renal or hepatic failure may be givenand adults with cardiac renal or hepatic failure may be givenexcessive dose the result of hyperosmaler effectexcessive dose the result of hyperosmaler effect
Chemotoxoicity :Chemotoxoicity : Toxic of C/M because ofitsintrinsicToxic of C/M because ofitsintrinsicstructurestructure
the electrical changesin the particle of the HOCM and ofthe electrical changesin the particle of the HOCM and ofhexaberix (sodiummeglumine ioxaglate ) is particularhexaberix (sodiummeglumine ioxaglate ) is particular
importance inintra coronary use the contains are clinicallyimportance inintra coronary use the contains are clinicallymoremore
toxic than anions and sodiumismore toxic thanmegluminetoxic than anions and sodiumismore toxic thanmeglumine
-
8/6/2019 Contrast Media and Adverse Effects
24/42
Anxiety :Anxiety : when C/M reaction as the result of the patientswhen C/M reaction as the result of the patients
fearfear
and apprehension. The high autonomic nervoussystemand apprehension. The high autonomic nervoussystemactivity in an anxious patient will be stimulated furtheractivity in an anxious patient will be stimulated further
whenwhen
the patients experiences the administration of contrastthe patients experiences the administration of contrast
media.media.
When compared with HOCM and LOCM resulted in lessWhen compared with HOCM and LOCM resulted in less
frequent ECG abnormalities and side effects.frequent ECG abnormalities and side effects.
Mechanism of contrast media reaction ContdMechanism of contrast media reaction Contd
-
8/6/2019 Contrast Media and Adverse Effects
25/42
Route of C/M AdministrationRoute of C/M Administration
Intravenous orintra arteriallyIntravenous orintra arterially
ManualManual
Powerinjector e.g. CT, angiographyPowerinjector e.g. CT, angiography
OrallyOrally Barium and TRAZO gastroBarium and TRAZO gastro
Per rectumPer rectum Per vaginalPer vaginal HSGHSG
Directsinto the sinusDirectsinto the sinus
-
8/6/2019 Contrast Media and Adverse Effects
26/42
SafetyPrecautionSafetyPrecaution
Pts history :Pts history : Careful history regarding allergy to iodine anyCareful history regarding allergy to iodine anycontrast agent any drug or food atomcontrast agent any drug or food atom
High risk of ptsHigh risk of pts
Pt with asthma thyroid and cardiac disorderPt with asthma thyroid and cardiac disorder
Pts with chronic seizure , diabetic nephropathy orPts with chronic seizure , diabetic nephropathy ormyelomamyeloma
Hepatic or renal failure impairmentHepatic or renal failure impairment
Pts with metabolic or hematological disorderPts with metabolic or hematological disorder
Unconscious and semi unconscious ptsUnconscious and semi unconscious pts Pts with history of allergy or a previous reaction to aPts with history of allergy or a previous reaction to a
contrast agentcontrast agent
InfantsInfants
Proper hydration of the ptsProper hydration of the pts
-
8/6/2019 Contrast Media and Adverse Effects
27/42
Ptsshould be will hydrated before the administration ofPtsshould be will hydrated before the administration ofC/MC/M
(contrast media)(contrast media)
Emergency equipment :Emergency equipment : emergency resuscitationemergency resuscitationequipmentequipment
and life saving / emergency drug should always beand life saving / emergency drug should always beavailableavailable
during the procedure and in the observation periodduring the procedure and in the observation periodfollowing thefollowing the
exposureexposure
Administration of C/MAdministration of C/M
It is preferable to use glasssyringeIt is preferable to use glasssyringe Pre testing for hypersensitivity reactionismandatoryPre testing for hypersensitivity reactionismandatory
c/mshould always be loaded in the syringe pullingc/mshould always be loaded in the syringe pullingthrough the needle through the rubber cap of the vialthrough the needle through the rubber cap of the vial
One vial to be uses for one pts only repeated use of aOne vial to be uses for one pts only repeated use of asin le vial isnot recommended.sin le vial isnot recommended.
-
8/6/2019 Contrast Media and Adverse Effects
28/42
Total dose and volume should be slowTotal dose and volume should be slow
Select appropriate dosing internal to ensure toSelect appropriate dosing internal to ensure to
complete clearance of contrast media from the bodycomplete clearance of contrast media from the body
Careful observation of pts during and afterCareful observation of pts during and after
administrationadministration The ptsmust be carefully observed during and afterThe ptsmust be carefully observed during and after
administration for at least half an hour asseriousadministration for at least half an hour asserious
delayed adverse reactionmay occurdelayed adverse reactionmay occur
Storage and utilization :Storage and utilization : Should be followed as explainedShould be followed as explainedonon
the pack. Discard the product if there change in colourthe pack. Discard the product if there change in colour
-
8/6/2019 Contrast Media and Adverse Effects
29/42
Advantages of contrast agentAdvantages of contrast agent
Better visualization tissue contrastBetter visualization tissue contrast
Better diagnosis of diseaseBetter diagnosis of disease
Conformation of diagnosisConformation of diagnosis
Disadvantage of C/MDisadvantage of C/M
Discomfort to the pts for contrast introductionDiscomfort to the pts for contrast introduction
Chances of various reactionis possibleChances of various reactionis possible Cost will be additional burden to the patient i.e. costlyCost will be additional burden to the patient i.e. costly
-
8/6/2019 Contrast Media and Adverse Effects
30/42
Advances reaction to contrast mediaAdvances reaction to contrast media
Principles :Principles : Adverse reaction can be reduced for appliedAdverse reaction can be reduced for applied
general principles of all patients. The smallest amount ofgeneral principles of all patients. The smallest amount of
contrast agent possible should be used for each producecontrast agent possible should be used for each produce
allowing at lest 48 hours to elapse between procedureallowing at lest 48 hours to elapse between procedure
AdverseAdverse reactionreaction toto contrastcontrast agentagent rangerange fromfrom aa mildmild
inconvenience,inconvenience, suchsuch asas itchingitching associatedassociated hiveshives toto aa lifelifethreateningthreatening emergencyemergency.. RenalRenal toxicitytoxicity isis wellwell knownknown
adverseadverse
reactionreaction associatedassociated withwith II..VV.. contrastcontrast materialmaterial
-
8/6/2019 Contrast Media and Adverse Effects
31/42
-
8/6/2019 Contrast Media and Adverse Effects
32/42
Contrast Media rise to various reactionContrast Media rise to various reaction
Minor reaction :Minor reaction : It includes UTCARIA, sneezing , flushing ,It includes UTCARIA, sneezing , flushing ,
nausia vomiting, tinnitus, violent becomes restlessnessnausia vomiting, tinnitus, violent becomes restlessness
usuallyno treatment is required only to reassure the patientusuallyno treatment is required only to reassure the patientissufficentsissufficents
Intermediate Reaction :Intermediate Reaction : Development of patches all over theDevelopment of patches all over the
body, nausia, vomiting and severe. Patient urge to coughbody, nausia, vomiting and severe. Patient urge to coughbloodblood
pressure raise up a down patients feeds drowsy, patientspressure raise up a down patients feeds drowsy, patients
sweating or feel cold and severingsweating or feel cold and severing
Need:Need: Treatment but no risk to the patientsTreatment but no risk to the patients
-
8/6/2019 Contrast Media and Adverse Effects
33/42
Major Reaction :Major Reaction : Bronchospasm, Laryngeal oedema patient pale,Bronchospasm, Laryngeal oedema patient pale,
sweating thready pulse may loss, consciousness. Respiratorysweating thready pulse may loss, consciousness. Respiratory
failure as the pts can be stop breathing convulsion and coma allfailure as the pts can be stop breathing convulsion and coma all
these required prompt and efficient treatment if to survive thethese required prompt and efficient treatment if to survive the
patientpatient
First line treatment of acute reaction to contrast mediaFirst line treatment of acute reaction to contrast media
Nausia/ vomitingNausia/ vomiting TransientTransient supportive treatmentsupportive treatment
Severe protectedSevere protected Appropriate antiemetic drugsshould beAppropriate antiemetic drugsshould beconsidered.considered.
Urticaria :Urticaria :
Scattered transient : Supportive treatment and observationScattered transient : Supportive treatment and observation
Scattered protected : Appropriate H1 antihistamineScattered protected : Appropriate H1 antihistamineintramuscularly orintravenouslyshould be consideredintramuscularly orintravenouslyshould be considered
Profound : Consider adrenaline (0.1Profound : Consider adrenaline (0.1-- 03mg) Transmuscularly03mg) TransmuscularlyIn adults 0.01mg/kgIn adults 0.01mg/kg
-
8/6/2019 Contrast Media and Adverse Effects
34/42
Bronchospasm :Bronchospasm :
Ox y gen bymark (6Ox y gen bymark (6--10 1/min)10 1/min)
B2 Agoinst metered dose inhaler (2B2 Agoinst metered dose inhaler (2--3 deep3 deepinhalation )inhalation )
AdrenalineAdrenaline
Normal blood pressureNormal blood pressureIntramuscular 2mgIntramuscular 2mg
In pediatric patientsIn pediatric patients 0.01mg/kg upto 0.3mg max0.01mg/kg upto 0.3mg max
Decreased blood pressureDecreased blood pressureIntramuscularIntramuscular 0.5ml adrenaline0.5ml adrenaline
In pediatric patients 0.01mg/kg intramuscularlyIn pediatric patients 0.01mg/kg intramuscularly
-
8/6/2019 Contrast Media and Adverse Effects
35/42
Laryngeal edema :Laryngeal edema :
Oxygen bymask (6Oxygen bymask (6--10 1/min)10 1/min)
Intramuscular adrenaline 0.5ml for adults ; repeat asIntramuscular adrenaline 0.5ml for adults ; repeat as
needed.needed.
Hypotension :Hypotension : Isolated hypotensionIsolated hypotension
Elevate patients legsElevate patients legs
Oxygen bymaskOxygen bymask Intravenous fluidIntravenous fluid rapidlynormal saline or lactated ringersrapidlynormal saline or lactated ringers
solutionsolution
If unresponsiveIf unresponsive adrenaline 0.5ml intramuscularly repeatadrenaline 0.5ml intramuscularly repeat
asneededasneeded Vagal reaction (hypotension and brody cardia)Vagal reaction (hypotension and brody cardia)
Elevate patients legsElevate patients legs
Oxygen bymask ( 6Oxygen bymask ( 6--10 1/min)10 1/min)
Atropine 0.6Atropine 0.6--10mg intravenously repeat ifnecessary after10mg intravenously repeat ifnecessary after33--5 minute to 3m total 0.04 m /k in adults5 minute to 3m total 0.04 m /k in adults
-
8/6/2019 Contrast Media and Adverse Effects
36/42
Pedatric patietns give 0.02 mg/kg i.v. max 0.6mg perPedatric patietns give 0.02 mg/kg i.v. max 0.6mg perdose) repeat necessary to 2mg totaldose) repeat necessary to 2mg total
Intravenous fluidsIntravenous fluids rapidlynormal saline or lactatatedrapidlynormal saline or lactatatedringersolutionringersolution
Generalized anaphylactoid reactionGeneralized anaphylactoid reaction
Call for resuscitation teamCall for resuscitation team
Suction airway asneededSuction airway asneeded
Elevate patients legsif hypotensiveElevate patients legsif hypotensive
Oxygen bymask ( 6Oxygen bymask ( 6--10 1/min)10 1/min)
Intramuscular adrenaline 0.5ml in adults repeat asIntramuscular adrenaline 0.5ml in adults repeat asneeded. In pediatric patients 0.01mg/kg to 0.3mg maxneeded. In pediatric patients 0.01mg/kg to 0.3mg maxdosedose
Intravenous fluids (normal saline, lactated ringers)Intravenous fluids (normal saline, lactated ringers)
HH11 Blocker eg diphendramine 25Blocker eg diphendramine 25--50mg intravenously50mg intravenously
-
8/6/2019 Contrast Media and Adverse Effects
37/42
Treatment guide line ofmajor reactionTreatment guide line ofmajor reaction
Erythema, uticaria and angio neurotic oedemaErythema, uticaria and angio neurotic oedema
It occurin the form of giant urticaria oedema of theIt occurin the form of giant urticaria oedema of thelarynax may occur causing. Respiratory obstructionlarynax may occur causing. Respiratory obstruction
and difficultyin respirationand difficultyin respiration Treatment oxygenshould be administrated in all casesTreatment oxygenshould be administrated in all cases
25mg phenerganis givenintravenouslysupplemented25mg phenerganis givenintravenouslysupplementedby the 0.5ml adriline solutioninsevere cases 100mg ofby the 0.5ml adriline solutioninsevere cases 100mg of
hydrocortisone is given.hydrocortisone is given. Pulmonary oedmaPulmonary oedma Initially patientsis giveInitially patientsis give 02ma in02ma in
addition to hydrocortisone 100mg i.v. (intravenous)addition to hydrocortisone 100mg i.v. (intravenous)given fallowed by 10 to 20ml of aminophylene by slowgiven fallowed by 10 to 20ml of aminophylene by slow
i.e. injectioni.e. injection
-
8/6/2019 Contrast Media and Adverse Effects
38/42
Hypotensive shock :Hypotensive shock : 02 is given theni.v. drip assoon as02 is given theni.v. drip assoon as
possible prednisolone 20 mg or hydrocortisone 100mg ispossible prednisolone 20 mg or hydrocortisone 100mg is
givengiven
i.v.i.v.
Cardiac arrest :Cardiac arrest : The hospital emergency teammust be callThe hospital emergency teammust be call
immediately and the patient ventilated by artificialimmediately and the patient ventilated by artificialrespirationrespiration
with brook airway.with brook airway.
The usual additional measure applied to emergencyThe usual additional measure applied to emergency
teamteam
applied for administration of adrenaline 1.0ml solution 1%applied for administration of adrenaline 1.0ml solution 1%
Sodium bicarbonate drip and 5 to 10ml calcium chloride inSodium bicarbonate drip and 5 to 10ml calcium chloride in
dosedose
-
8/6/2019 Contrast Media and Adverse Effects
39/42
Extravasation of contrast materialExtravasation of contrast material
Tissue damage ismore likely to occur with extravasationTissue damage ismore likely to occur with extravasation
ofof
ionic contrast material then with nonionic content agentsionic contrast material then with nonionic content agentsControl :Control : Applicationice packs and heating pad, andApplicationice packs and heating pad, and
elevation are used to alleviate the symptoms associatedelevation are used to alleviate the symptoms associated
withwith
extravasation of contrast materialextravasation of contrast material
-
8/6/2019 Contrast Media and Adverse Effects
40/42
ConvulsionConvulsion
With the help ofintubations and positive pressureWith the help ofintubations and positive pressurerespirationrespiration
Initially thiopentone tone is administrated byslow i.v.Initially thiopentone tone is administrated byslow i.v.injection.injection.
First line of emergency drugs and instruments whichFirst line of emergency drugs and instruments whichshould be examinationshould be examination
Avil 2ml antihistamineAvil 2ml antihistamine allergic reactionallergic reaction
Hydrcortinsteroid fast actionHydrcortinsteroid fast action-- multipurpose life savingmultipurpose life saving AdrenalineAdrenaline Reduced secretion from bronchial andReduced secretion from bronchial and
salivary glandsalivary gland
DiazopamDiazopam Sedative (anti convulsive)Sedative (anti convulsive)
BuscopanBuscopan AntispasmodicAntispasmodic
-
8/6/2019 Contrast Media and Adverse Effects
41/42
AtropineAtropine
Normal salineNormal saline
Dextrose solutionDextrose solution
Antihistamine H1Antihistamine H1 Suitable forinjectionSuitable forinjection
BitaBita -- 2 against meter dose inhaler2 against meter dose inhaler
i.v. fluidsi.v. fluids normal saline or ringersolutionnormal saline or ringersolution
SphygmomanometerSphygmomanometer
OneOne
Oxygenshould be administrated in all casesOxygenshould be administrated in all cases
StethoscopeStethoscope
Drip standDrip stand
Emergency trollyEmergency trolly
Emergency trollysettingEmergency trollysetting
Ventilator defibrillatorVentilator defibrillator
-
8/6/2019 Contrast Media and Adverse Effects
42/42